Ionis Pharmaceuticals IONS Net investment gains (losses)
Net investment gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's net investment gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's net investment gains (losses)?
- Ionis Pharmaceuticals (IONS) reported net investment gains (losses) of $22.58M in Q1 2026.
- How has Ionis Pharmaceuticals's net investment gains (losses) changed year-over-year?
- Ionis Pharmaceuticals's net investment gains (losses) increased by 1321.4% year-over-year, from -$1.85M to $22.58M.
- What does net investment gains (losses) mean?
- The net profit or loss generated from the company's investment portfolio.
- How do you interpret net investment gains (losses)?
- An increase reflects strong treasury performance or favorable market conditions, while a decrease indicates market volatility or poor investment selection.
- How does net investment gains (losses) compare across companies?
- Common for cash-rich biotech firms; peers with large cash balances often report significant investment income or losses.